Baxter International Inc. vs. ClearPoint Neuro, Inc. Common Stock
BAX
Baxter International Inc.
$27.33 -3.60%
VS CLPTClearPoint Neuro, Inc. Common Stock
$13.16 +2.21%
Baxter International Inc. and ClearPoint Neuro, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| BAX | CLPT | |
|---|---|---|
| Market Cap | $14.13 billion | $401.44 million |
| Revenue (TTM) | $11.47 billion | — |
| Net Income (TTM) | $-1,063,000,000 | — |
BAX leads on 1 of 1 size & scale factors.
Valuation
| BAX | CLPT | |
|---|---|---|
| Price / Book | 2.29 | — |
| Price / Sales | 1.23 | — |
BAX and CLPT split the valuation factors evenly.
Profitability
| BAX | CLPT | |
|---|---|---|
| Net Margin | -9.27% | — |
| Return on Equity | -17.20% | — |
BAX and CLPT split the profitability factors evenly.
Dividend
| BAX | CLPT | |
|---|---|---|
| Dividend Yield | 0.15% | — |
BAX and CLPT split the dividend factors evenly.
Risk & Sentiment
| BAX | CLPT | |
|---|---|---|
| Short Interest | 1.03% | 0.17% |
CLPT leads on 1 of 1 risk & sentiment factors.
Dig deeper: BAX overview, BAX financials, CLPT overview, CLPT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.